The Role of Active Metabolites in Drug Toxicity
暂无分享,去创建一个
Munir Pirmohamed | M. Pirmohamed | N. Kitteringham | B. Kevin Park | Neil R. Kitteringham | B. Kevin Park | B. K. Park
[1] J. Gage. The action of paraquat and diquat on the respiration of liver cell fractions. , 1968, The Biochemical journal.
[2] M. Brin,et al. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.
[3] S. F. Sullivan,et al. The effect of acidosis on sympatho-adrenal stimulation. Particular reference to cardiopulmonary bypass. , 1966, JAMA.
[4] S. Spielberg,et al. In vitro evaluation of a toxic metabolite of sulfadiazine. , 1985, Canadian journal of physiology and pharmacology.
[5] S. Sternberg,et al. Cyclophosphamide and urinary bladder toxicity. , 1961, Cancer research.
[6] Z. Rossetti,et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. , 1988, Biochemical pharmacology.
[7] W. Mccaughey. A summary of the National Halothane Study. , 1972, British journal of anaesthesia.
[8] R. Diasio,et al. Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora , 1986, Antimicrobial Agents and Chemotherapy.
[9] D. Morin,et al. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey. , 1992, The Journal of pharmacology and experimental therapeutics.
[10] L. Seeff,et al. Acetaminophen hepatotoxicity in alcoholics. A therapeutic misadventure. , 1986, Annals of internal medicine.
[11] P. Dayer,et al. Fetal Drug Metabolism and Its Possible Clinical Implications , 1991, Clinical pharmacokinetics.
[12] D. Calne,et al. AETIOLOGY OF PARKINSON'S DISEASE , 1983, The Lancet.
[13] T. Devereux,et al. Xenobiotic metabolism by isolated pulmonary cells. , 1989, Pharmacology & therapeutics.
[14] C. W. Parker. Allergic reactions in man. , 1982, Pharmacological reviews.
[15] N. Kitteringham,et al. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. , 1988, British journal of clinical pharmacology.
[16] S. Spielberg,et al. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.
[17] A. Herbst,et al. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update. , 1987 .
[18] G. Bryan,et al. METABOLISM AND DISPOSITION OFN-{4-(5-NITRO-2-FURYL)-[2-14C]THIAZOLYL}ACETAMIDEIN THE RAT , 1975 .
[19] F. Robicsek. Acute methemoglobinemia during cardiopulmonary bypass caused by intravenous nitroglycerin infusion. , 1985, The Journal of thoracic and cardiovascular surgery.
[20] C. Laskin,et al. Autoantibodies in alcoholic liver disease. , 1990, The American journal of medicine.
[21] D. Wortham,et al. Comparison of the Effect of the Macrolide Antibiotics Erythromycin, Clarithromycin and Azithromycin on Terfenadine Steady-State Pharmacokinetics and Electrocardiographic Parameters , 1994 .
[22] J. Castro,et al. Carcinoma of the bladder complicating cyclophosphamide therapy. , 1975, British journal of urology.
[23] G. Duggin,et al. Mechanisms in the development of analgesic nephropathy. , 1980, Kidney international.
[24] P. Cox. Cyclophosphamide cystitis--identification of acrolein as the causative agent. , 1979, Biochemical pharmacology.
[25] T. Kumazawa,et al. Toxicity following methoxyflurane anaesthesia , 1970, Canadian Anaesthetists' Society journal.
[26] J. Oates,et al. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. , 1978, The New England journal of medicine.
[27] A. Breckenridge,et al. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. , 1992, British journal of clinical pharmacology.
[28] T. Vree,et al. Adverse reactions to co-trimoxazole in HIV infection: a reappraisal of the glutathione-hydroxylamine hypothesis. , 1996, The Journal of antimicrobial chemotherapy.
[29] J. Timbrell. Principles of biochemical toxicology , 1991 .
[30] J. Halperin,et al. Neuroactive kynurenines in Lyme borreliasis , 1992, Neurology.
[31] R. Pounder,et al. Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. , 1975, Gut.
[32] B McNutt,et al. Torsades de pointes occurring in association with terfenadine use. , 1991, JAMA.
[33] J. Jimenez,et al. DNA damage in intact cells induced by bacterial metabolites of chloramphenicol , 1988, American journal of hematology.
[34] N. T. Smith,et al. Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. , 1977, Anesthesiology.
[35] G. Barr,et al. Renal Effects and Metabolism of Isoflurane in Man , 1974, Anesthesiology.
[36] W. Seinen,et al. Autoimmunity and Toxicology: Immune Disregulation Induced by Drugs and Chemicals , 1989 .
[37] T. Stillwell,et al. Cyclophosphamide‐induced hemorrhagic cystitis: A review of 100 patients , 1988, Cancer.
[38] D. V. Von Hoff,et al. Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases. , 1977, The American journal of medicine.
[39] R. Finnell,et al. Clinical and experimental studies linking oxidative metabolism to phenytoin-induced teratogenesis. , 1992, Neurology.
[40] J. Shelley. Pharmacological mechanisms of analgesic nephropathy. , 1978, Kidney international.
[41] A. S. Gross,et al. The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects. , 1990, Pharmacology & therapeutics.
[42] Wolf Cr. Individuality in cytochrome P450 expression and its association with the nephrotoxic and carcinogenic effects of chemicals. , 1991 .
[43] F. Freiha,et al. Hemorrhagic cystitis: a review. , 1990, The Journal of urology.
[44] R. Woosley,et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin , 1992, Clinical pharmacology and therapeutics.
[45] R. V. van Oers,et al. Effects of recombinant human granulocyte colony‐stimulating factor on leucopenia in zidovudine‐treated patients with AIDS and AIDS related complex, a phase I/II study , 1991, British journal of haematology.
[46] P. Killenberg,et al. Acetaminophen hepatotoxicity. An alternative mechanism. , 1983, Biochemical pharmacology.
[47] A. Yunis,et al. Chloramphenicol: relation of structure to activity and toxicity. , 1988, Annual review of pharmacology and toxicology.
[48] J. Langston,et al. Aetiology of Parkinsońs disease , 1983 .
[49] N. Kitteringham,et al. Structural requirements for bioactivation of anticonvulsants to cytotoxic metabolites in vitro. , 1989, British journal of clinical pharmacology.
[50] E. Kharasch,et al. Identification of Cytochrome P450 2E1 as the Predominant Enzyme Catalyzing Human Liver Microsomal Defluorination of Sevoflurane, Isoflurane, and Methoxyflurane , 1993, Anesthesiology.
[51] K Farrell,et al. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[52] M. Murray,et al. Renal toxicity of the nonsteroidal anti-inflammatory drugs. , 1993, Annual review of pharmacology and toxicology.
[53] H. Satoh,et al. The immunologic and metabolic basis of drug hypersensitivities. , 1988, Annual review of pharmacology and toxicology.
[54] S. Wallace,et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.
[55] H. Zimmerman,et al. Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .
[56] M. Pirmohamed,et al. Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine. , 1991, British journal of clinical pharmacology.
[57] B. Burchell,et al. UDP-glucuronosyltransferases: a family of detoxifying enzymes. , 1990, Trends in pharmacological sciences.
[58] D. Nebert,et al. Genes for cytochrome P-450 and their regulation. , 1986, CRC critical reviews in biochemistry.
[59] M. Pirmohamed,et al. Idiosyncratic reactions to antidepressants: a review of the possible mechanisms and predisposing factors. , 1992, Pharmacology & therapeutics.
[60] R. Morrison,et al. Renal failure following methoxyflurane analgesia. , 1987, The New Zealand medical journal.
[61] S. Snyder,et al. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[62] S. Hammer,et al. Zidovudine: Five Years Later , 1992, Annals of Internal Medicine.
[63] J. Sommadossi,et al. Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. , 1989, Molecular pharmacology.
[64] R. Birge,et al. Selective protein arylation by acetaminophen and 2,6-dimethylacetaminophen in cultured hepatocytes from phenobarbital-induced and uninduced mice. Relationship to cytotoxicity. , 1989, Biochemical pharmacology.
[65] A. Stanners,et al. Torsades de pointes complicating treatment with terfenadine. , 1991, BMJ.
[66] O. Niemelä,et al. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. , 1991, The Journal of clinical investigation.
[67] M. Yaqoob,et al. Renal impairment with chronic hydrocarbon exposure. , 1993, The Quarterly journal of medicine.
[68] W. Hofmann,et al. Fatal Liver Failure in 16 Children with Valproate Therapy , 1988, Epilepsia.
[69] T. Kelly. Teratogenicity of anticonvulsant drugs. I: Review of the literature. , 1984, American journal of medical genetics.
[70] A. Primack. Amelioration of cyclophosphamide-induced cystitis. , 1971, Journal of the National Cancer Institute.
[71] D. Greenberg,et al. Endothelins and the nervous system , 1992, Neurology.
[72] A. T. Williams,et al. Carbon Tetrachloride Hepatotoxicity: An Example of Free Radical-Mediated Injury , 1990, Seminars in liver disease.
[73] M. Pirmohamed,et al. Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes. , 1991, British journal of clinical pharmacology.
[74] D M Clive,et al. Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.
[75] M. Boyd,et al. Superoxide and hydrogen peroxide production and NADPH oxidation stimulated by nitrofurantoin in lung microsomes: possible implications for toxicity. , 1979, Life sciences.
[76] C. Day,et al. Genetic predisposition to alcoholic liver disease. , 1992, Gut.
[77] C. Goldsmith,et al. Is enflurane hepatotoxic? , 1986, Anesthesia and analgesia.
[78] J Kao,et al. Cutaneous metabolism of xenobiotics. , 1990, Drug metabolism reviews.
[79] F. Dreifuss,et al. Valproic acid hepatic fatalities. , 1989, Neurology.
[80] Fetal hydantoin syndrome. , 1975, Lancet.
[81] R. Mason,et al. Possible role of free radical formation in clozapine (clozaril)-induced agranulocytosis. , 1991, Molecular pharmacology.
[82] J. A. Page,et al. Cardiotoxicity of adriamycin and related anthracyclines. , 1976, Cancer treatment reviews.
[83] M. Rawlins. Pathogenesis of adverse drug reactions , 1977 .
[84] B. K. Park,et al. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system. , 1990, British journal of clinical pharmacology.
[85] K. Chiba,et al. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. , 1984, Biochemical and biophysical research communications.
[86] H. Prentice,et al. Treatment of cyclophosphamide-induced cystitis with prostaglandin E2. , 1984, Annals of internal medicine.
[87] A. Yunis,et al. Drug-induced red cell dyscrasias. , 1989, Blood reviews.
[88] A. Fantel,et al. Xenobiotic biotransformation/bioactivation in organogenesis-stage conceptual tissues: implications for embryotoxicity and teratogenesis. , 1992, Drug metabolism reviews.
[89] Spielberg Sp. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans. , 1984 .
[90] E. Jeffery. Human Drug Metabolism: From Molecular Biology to Man , 1992 .
[91] B. Levine. Immunochemical Mechanisms Involved in Penicillin Hypersensitivity in Experimental Animals and in Human Beings , 1964, Federation proceedings.
[92] D. Roden,et al. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide. , 1980, The American journal of cardiology.
[93] J. Hanson. Teratogen update: fetal hydantoin effects. , 1986, Teratology.
[94] D. Jerina,et al. Arene oxides: a new aspect of drug metabolism. , 1974, Science.
[95] M. Page,et al. The mechanisms of reactions of .beta.-lactam antibiotics , 1984 .
[96] G. Rodgers,et al. Hematologic aspects of human immunodeficiency virus infection: Laboratory and clinical considerations , 1988, American journal of hematology.
[97] L. Goldsmith. Physiology, biochemistry, and molecular biology of the skin , 1991 .
[98] W. Evans,et al. Age-related adriamycin cardiotoxicity in children. , 1978, Cancer treatment reports.
[99] K. Benitz,et al. Renal Toxicity of Tetracycline Degradation Products , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[100] C. R. Spence,et al. The incidence of bladder cancer after cyclophosphamide therapy. , 1979, The Journal of urology.
[101] J. Neuberger. Halothane and Hepatitis , 1990 .
[102] J. Kao. Estimating the Contribution by Skin to Systemic Metabolism , 1988, Annals of the New York Academy of Sciences.
[103] R. Baldessarini,et al. Clozapine. A novel antipsychotic agent. , 1991, The New England journal of medicine.
[104] R. Day,et al. Clinical pharmacology of non-steroidal anti-inflammatory drugs. , 1987, Pharmacology & therapeutics.
[105] J. Groopman,et al. Haematologic manifestations of the human immune deficiency virus (HIV) , 1987, British journal of haematology.
[106] D. Jollow,et al. Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. , 1988, The Journal of pharmacology and experimental therapeutics.
[107] R. Branch,et al. Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4. , 1992, Molecular pharmacology.
[108] M. Juchau. Bioactivation in chemical teratogenesis. , 1989, Annual review of pharmacology and toxicology.
[109] S. Nelson. Molecular Mechanisms of the Hepatotoxicity Caused by Acetaminophen , 1990, Seminars in liver disease.
[110] P. Eyer,et al. Formation and disposition of nitrosochloramphenicol in rat liver. , 1985, Biochemical pharmacology.
[111] L. L. Smith,et al. The relevance of pentose phosphate pathway stimulation in rat lung to the mechanism of paraquat toxicity. , 1976, Biochemical pharmacology.
[112] D. Fine,et al. Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro , 1983 .
[113] C. Wolf,et al. Evidence that the androgen receptor mediates sexual differentiation of mouse renal cytochrome P450 expression. , 1991, The Biochemical journal.
[114] C. L. Ferguson,et al. Torsades de pointes occurring in association with terfenadine use. , 1990, JAMA.
[115] A. Pisciotta. Drug-induced agranulocytosis. Peripheral destruction of polymorphonuclear leukocytes and their marrow precursors. , 1990, Blood reviews.
[116] F. Muggia,et al. Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529). , 1990, Pharmacology & therapeutics.
[117] R. Stern,et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. , 1990 .
[118] M. Cousins,et al. Renal toxicity of anaesthetics: With specific references to the nephrotoxicity of methoxyflurane , 1973, Canadian Anaesthetists' Society journal.
[119] R. Bevan,et al. Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells. , 1991, Molecular pharmacology.
[120] T. Baillie,et al. Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[121] I. Ifrim,et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. , 1977, Science.
[122] G. Alexander,et al. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine , 1990, The Lancet.
[123] J. Kehrer,et al. Cooxidation of cyclophosphamide as an alternative pathway for its bioactivation and lung toxicity. , 1991, Cancer research.
[124] H. Thurston,et al. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype. , 1987, The Quarterly journal of medicine.
[125] F. Dreifuss,et al. Valproic acid hepatic fatalities , 1987, Neurology.
[126] M. Boyd. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung , 1977, Nature.
[127] J. Groopman,et al. Hematologic manifestations of the human immune deficiency virus (HIV). , 1988, Seminars in hematology.
[128] A. Miller,et al. Nitroso-chloramphenicol: possible mediator in chloramphenicol-induced aplastic anemia. , 1980, The Journal of laboratory and clinical medicine.
[129] B. Kerr,et al. INHIBITION OF EPOXIDE HYDROLASE BY ANTICONVULSANTS AND RISK OF TERATOGENICITY , 1989, The Lancet.
[130] D. Pessayre,et al. Effects of erythromycin on hepatic drug-metabolizing enzymes in humans. , 1983, Biochemical pharmacology.
[131] R. Hook,et al. Pharmacokinetics and biotransformation studies of terfenadine in man. , 1982, Arzneimittel-Forschung.
[132] M. Miller,et al. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[133] O. Kofman. Deprenyl: Protective vs. Symptomatic Effect , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[134] M. Tirmenstein,et al. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3'-hydroxyacetanilide, in mouse liver. , 1989, The Journal of biological chemistry.
[135] A. Forbes,et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. , 1991, BMJ.
[136] J. Neuberger,et al. Evidence for expression in human liver of halothane‐induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis , 1988, Hepatology.
[137] J. Tredger,et al. Long-Term Anticonvulsant Therapy Worsens Outcome in Paracetamol-Induced Fulminant Hepatic Failure , 1992, Human & experimental toxicology.
[138] G. Bakris,et al. Acute Interstitial Nephritis with Glomerulopathy Due to Nonsteroidal Anti‐Inflammatory Agents: A Review of Its Clinical Spectrum and Effects of Steroid Therapy , 1990, Journal of clinical pharmacology.
[139] H. Satoh,et al. Enflurane Metabolism Produces Covalently Bound Liver Adducts Recognized by Antibodies from Patients with Halothane Hepatitis , 1988, Anesthesiology.
[140] R. Blaese,et al. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[141] J. Lieberman,et al. Update on the clinical efficacy and side effects of clozapine. , 1991, Schizophrenia bulletin.
[142] H. Sewell,et al. The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. , 1988, British journal of clinical pharmacology.
[143] J. Patel,et al. Metabolism and pulmonary toxicity of cyclophosphamide. , 1990, Pharmacology & therapeutics.
[144] J. Uetrecht. Metabolism of drugs by activated leukocytes: implications for drug-induced lupus and other drug hypersensitivity reactions. , 1991, Advances in experimental medicine and biology.
[145] P. Bk. Metabolic Basis of Adverse Drug Reactions , 1986, Journal of the Royal College of Physicians of London.
[146] P. G. Wells,et al. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. , 1992, Gastroenterology.
[147] D. Pessayre,et al. Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats. , 1983, Biochemical pharmacology.
[148] S. Chaplin. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II. , 1986, Adverse drug reactions and acute poisoning reviews.
[149] D. White,et al. Bleomycin-induced pulmonary toxicity. , 1990, Clinics in chest medicine.
[150] R. Balling,et al. Oxidative and conjugative metabolism of diethylstilbestrol by rabbit preimplantation embryos. , 1985, Developmental Biology.
[151] A. Salama,et al. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. , 1985, The New England journal of medicine.
[152] S. Nelson,et al. Oxidation of acetaminophen to N-acetyl-p-aminobenzoquinone imine by human CYP3A4. , 1993, Biochemical pharmacology.
[153] K. Ormstad,et al. Renal transport and disposition of Na‐2‐mercaptoethane sulfonate disulfide (Dimesna) in the rat , 1982, FEBS letters.
[154] G. Powis,et al. Enzymatic and non-enzymatic reduction of N-acetyl-p-benzoquinone imine and some properties of the N-acetyl-p-benzosemiquinone imine radical. , 1984, Biochemical pharmacology.
[155] D. Devine,et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. , 1992, The New England journal of medicine.
[156] L. Benet,et al. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? , 1992, Drug metabolism reviews.
[157] S. Spielberg,et al. Acetaminophen toxicity in human lymphocytes in vitro. , 1980, The Journal of pharmacology and experimental therapeutics.
[158] J. Doroshow,et al. The effect of doxorubicin on hepatic and cardiac glutathione. , 1979, Research communications in chemical pathology and pharmacology.
[159] R. Aur,et al. Cyclophosphamide‐induced hemorrhagic cystitis in children with leukemia , 1975, Cancer.
[160] Anthony E. Lang,et al. Effect of deprenyl on the progression of disability in early Parkinson's disease. , 1989, The New England journal of medicine.
[161] B. Habibi,et al. NOMIFENSINE-INDUCED IMMUNE HÆMOLYTIC ANÆMIA AND IMPAIRED RENAL FUNCTION , 1979, The Lancet.
[162] M. H. Gault,et al. Toxic nephropathy after low-dose methoxyflurane anesthesia: drug interaction with secobarbital? , 1976, Canadian Medical Association journal.
[163] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.
[164] S. Spielberg,et al. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs. , 1990, Molecular pharmacology.
[165] B. Longley,et al. Immunology and the Skin Current Concepts , 1988, Annals of the New York Academy of Sciences.
[166] C. V. Smith,et al. Alkylation of the liver plasma membrane and inhibition of the Ca2+ ATPase by acetaminophen. , 1988, Biochemical pharmacology.
[167] L. Benet,et al. Irreversible binding of zomepirac to plasma protein in vitro and in vivo. , 1986, The Journal of clinical investigation.
[168] H. Mukhtar,et al. Cutaneous cytochrome P-450. , 1989, Drug metabolism reviews.
[169] J. Mason,et al. Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver. , 1984, Drug metabolism and disposition: the biological fate of chemicals.
[170] R D Olson,et al. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin. , 1980, The Journal of pharmacology and experimental therapeutics.
[171] P. Carrupt,et al. The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism. , 1990, Drug metabolism reviews.
[172] E. Andermann,et al. GENETIC PREDISPOSITION TO PHENYTOIN-INDUCED BIRTH DEFECTS , 1985, The Lancet.
[173] P. Loiseau,et al. Inhibition of human liver microsomal epoxide hydrolase by valproate and valpromide: In vitro/in vivo correlation , 1989, Clinical pharmacology and therapeutics.
[174] C. Dollery,et al. HYDRALAZINE-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUS: INFLUENCE OF HLA-DR AND SEX ON SUSCEPTIBILITY , 1980, The Lancet.
[175] A. Breckenridge,et al. Inhibition of Dapsone‐induced Methaemoglobinaemia in the Rat Isolated Perfused Liver , 1990, The Journal of pharmacy and pharmacology.
[176] J. Bauer,et al. Immediate rise in intracellular calcium and glycogen phosphorylase a activities upon acetaminophen covalent binding leading to hepatotoxicity in mice. , 1988, Toxicology.
[177] D. Davies,et al. Textbook of Adverse Drug Reactions , 1992, Annals of Internal Medicine.
[178] R. Roman,et al. Renal tubular site of action of fluoride in Fischer 344 rats. , 1977, Anesthesiology.
[179] M. Pirmohamed,et al. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. , 1992, Biochemical pharmacology.
[180] S. Snyder,et al. II. Neuromelanin: A role in MPTP-induced neurotoxicity , 1987 .
[181] E Scowen,et al. Committee on Safety of Medicines. , 1978, British journal of anaesthesia.
[182] N. Kitteringham,et al. Drug disposition and drug hypersensitivity. , 1987, Biochemical pharmacology.
[183] A. Benson,et al. Biochemical determinants of Adriamycin toxicity in mouse liver, heart and intestine. , 1992, Biochemical pharmacology.
[184] U. Christen,et al. Mechanisms of halothane toxicity: novel insights. , 1993, Pharmacology & therapeutics.
[185] D. Morin,et al. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene. , 1992, The Journal of pharmacology and experimental therapeutics.
[186] B. Brodie,et al. THE FATE OF ACETOPHENETIDIN (PHENACETIN) IN MAN AND METHODS FOR THE ESTIMATION OF ACETOPHENETIDIN AND ITS METABOLITES IN BIOLOGICAL MATERIAL , 1949 .
[187] J. Uetrecht. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions. , 1992, Drug metabolism reviews.
[188] F. V. van Pelt,et al. Immunohistochemical detection of cytochrome P450 isoenzymes in cultured human epidermal cells. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[189] D. Wortham,et al. The effect of fluconazole on the steady‐state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans , 1993, Clinical pharmacology and therapeutics.
[190] T. Myers,et al. Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac. , 1993, Chemical research in toxicology.
[191] J. Langston,et al. MPTP and parkinson's disease , 1985, Trends in Neurosciences.
[192] M. Boyd,et al. Metabolic activation of nitrofurantoin--possible implications for carcinogenesis. , 1979, Biochemical pharmacology.
[193] A. Mclean. Why do patients still die from paracetamol poisoning? , 1986, British medical journal.
[194] R. Lewin. Trail of ironies to Parkinson's disease. , 1984, Science.
[195] Parker Cw. IMMUNOCHEMICAL MECHANISMS IN PENICILLIN ALLERGY. , 1965 .
[196] J. de Jersey,et al. Antibodies against acetaldehyde-modified epitopes: presence in alcoholic, non-alcoholic liver disease and control subjects. , 1990, Alcohol and alcoholism.
[197] L. L. Smith. Mechanism of Paraquat Toxicity in Lung and its Relevance to Treatment , 1987, Human toxicology.
[198] M. R. Boyd,et al. Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.
[199] N. Adkinson,et al. Immediate hypersensitivity reactions to penicillin and related antibiotics , 1988, Clinical allergy.
[200] Harman Aw. The effectiveness of antioxidants in reducing paracetamol-induced damage subsequent to paracetamol activation. , 1985 .
[201] L. Benet,et al. Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein. , 1991, Drug metabolism and disposition: the biological fate of chemicals.
[202] R. Martino,et al. Direct detection of new flucytosine metabolites in human biofluids by 19F nuclear magnetic resonance. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[203] A. Pablos-Mendez,et al. Clinical Features and Management of Severe Dermatological Reactions to Drugs , 1990, Drug safety.
[204] L. Pohl. Drug-Induced Allergic Hepatitis , 1990, Seminars in liver disease.
[205] J. Unadkat,et al. Adverse reactions to co-trimoxazole in HIV infection , 1991, The Lancet.
[206] T. Woolf,et al. Basic Concepts in Drug Metabolism: Part II , 1987, Journal of clinical pharmacology.
[207] F. Guengerich. Metabolic activation of carcinogens. , 1992, Pharmacology & therapeutics.
[208] S. Snyder,et al. Characterization of the Binding of N‐Methyl‐4‐Phenylpyridine, the Toxic Metabolite of the Parkinsonian Neurotoxin N‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine, to Neuromelanin , 1987, Journal of Neurochemistry.
[209] P. Gell,et al. Clinical aspects of immunology , 1968 .
[210] J. Neuberger,et al. Halothane hepatitis: a model of immune mediated drug hepatotoxicity. , 1987, Clinical science.
[211] M. Droller,et al. Prevention of cyclophosphamide-induced hemorrhagic cystitis. , 1982, Urology.
[212] J. Trudell,et al. Methoxyflurane Metabolism and Renal Dysfunction: Clinical Correlation in Man , 1971, Anesthesiology.
[213] D. Lindhout. Pharmacogenetics and drug interactions: role in antiepileptic-drug-induced teratogenesis. , 1992, Neurology.
[214] J. Aronson,et al. Oxford Textbook of Clinical Pharmacology and Drug Therapy , 1985 .
[215] J. Jimenez,et al. Aerobic nitroreduction of dehydrochloramphenicol by bone marrow. , 1988, Toxicology and applied pharmacology.
[216] W. Nicklas,et al. Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium , 1986, Journal of neurochemistry.
[217] H. Satoh,et al. Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis. , 1988 .
[218] T. Baillie,et al. Cytochrome P-450--catalyzed formation of delta 4-VPA, a toxic metabolite of valproic acid. , 1987, Science.
[219] M. Rieder,et al. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites. , 1989, Annals of internal medicine.
[220] Yunis Aa. Chloramphenicol toxicity: 25 years of research. , 1989 .
[221] C. M. Leevy,et al. Lymphocyte transformation and alcoholic liver injury. , 1972, Gastroenterology.
[222] G. Gordon,et al. Predisposition to phenytoin hepatotoxicity assessed in vitro. , 1981, The New England journal of medicine.
[223] W. Johnson,et al. Urinary-bladder fibrosis and telangiectasia associated with long-term cyclophosphamide therapy. , 1971, The New England journal of medicine.
[224] C. Lieber,et al. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. , 1989, Archives of biochemistry and biophysics.
[225] P. Moldéus,et al. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. , 1985, Molecular pharmacology.
[226] H. Satoh,et al. Neoantigens associated with halothane hepatitis. , 1989, Drug metabolism reviews.
[227] A. Breckenridge,et al. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man. , 1990, British journal of clinical pharmacology.
[228] S. Snyder,et al. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity , 1987, Nature.
[229] S. Nelson,et al. Stereoselectivity of naphthalene epoxidation by mouse, rat, and hamster pulmonary, hepatic, and renal microsomal enzymes. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[230] C. Lieber. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. , 1988, The New England journal of medicine.
[231] R. Zetterman. Autoimmunity and alcoholic liver disease. , 1990, The American journal of medicine.
[232] M. Pirmohamed,et al. Lack of interaction between sulphasalazine and cimetidine in patients with rheumatoid arthritis. , 1993, British journal of rheumatology.
[233] B. Lauterburg,et al. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. , 1988, Gut.
[234] J. Critchley,et al. Acute haemolysis and renal failure after nomifensine overdosage. , 1980, British medical journal.
[235] B B Brodie,et al. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.
[236] N. Abraham,et al. Role of heme metabolism in AZT‐induced bone marrow toxicity , 1990, American journal of hematology.
[237] J. K. Hurst,et al. Leukocytic oxygen activation and microbicidal oxidative toxins. , 1989, Critical reviews in biochemistry and molecular biology.
[238] G. Gordon,et al. Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism. , 1981, The Journal of clinical investigation.
[239] M. Pirmohamed,et al. An investigation of the formation of cytotoxic, genotoxic, protein-reactive and stable metabolites from naphthalene by human liver microsomes. , 1993, Biochemical pharmacology.
[240] R. Kauffman,et al. Metabolism and pharmacokinetics of acetaminophen in a severely poisoned young child. , 1984, The Journal of pediatrics.
[241] B. Stricker,et al. Drug-induced hepatic injury. A comprehensive survey of the literature on adverse drug reactions up to January 1985. , 1985 .
[242] R. Olson,et al. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[243] Steven D. Cohen,et al. Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. , 1988, Toxicology and applied pharmacology.
[244] Y. Israel,et al. Antibodies against acetaldehyde‐modified protein epitopes in human alcoholics , 1987, Hepatology.
[245] A. Breckenridge,et al. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. , 1989, British journal of clinical pharmacology.
[246] M. Pirmohamed,et al. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. , 1992, British journal of clinical pharmacology.
[247] T. Quinn,et al. More on routine HIV screening. , 1993, The New England journal of medicine.
[248] D. V. Vander Jagt,et al. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. , 1994, Molecular pharmacology.
[249] D. Morin,et al. Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung. , 1991, The Journal of pharmacology and experimental therapeutics.
[250] J A Lieberman,et al. A Report of Clozapine-Induced Agranulocytosis in the United States , 1992, Drug safety.
[251] M. Pirmohamed,et al. The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes. , 1992, Biochemical pharmacology.
[252] M. Tirmenstein,et al. Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides. , 1990, The Journal of biological chemistry.
[253] P. Watkins. Role of Cytochromes P45O in Drug Metabolism and Hepatotoxicity , 1990, Seminars in liver disease.
[254] D. Drayer,et al. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide. , 1979, The New England journal of medicine.
[255] L. Klassen,et al. Immune responses to acetaldehyde-protein adducts: role in alcoholic liver disease. , 1992, Gastroenterology.
[256] M. Goto,et al. Teratogenicity of Antiepileptic Drugs: Analysis of Possible Risk Factors , 1988, Epilepsia.
[257] B. Brodie,et al. ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. III. CYTOCHROME P-450-MEDIATED COVALENT BINDING IN VITRO , 1973 .